Showing results (1131-1140 of 1,370) with videos related to
Sort By:
Pageof 137
European Heart Journal. Cardiovascular Pharmacotherapy|June 18, 2021
Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trialsAlexander P Benz, Isabelle Johansson, Willem J M Dewilde, et al.Journal of the American College of Cardiology|June 29, 2019
Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS TrialSonia S Anand, John W Eikelboom, Leanne Dyal, et al.Journal of Medicinal Chemistry|March 18, 2005
Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitorsGee-Hong Kuo, Aihua Wang, Stuart Emanuel, et al.International Journal of Clinical Practice|April 6, 2013
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillationK Huber, S J Connolly, A Kher, et al.Journal of Medicinal Chemistry|June 25, 2005
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activitiesRonghui Lin, Peter J Connolly, Shenlin Huang, et al.European Heart Journal|October 26, 2017
A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk scoreZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.European Heart Journal. Acute Cardiovascular Care|November 8, 2018
Atrial fibrillation detected initially during acute medical illness: A systematic reviewWilliam F McIntyre, Kevin J Um, Christopher C Cheung, et al.Lancet (London, England)|April 9, 2016
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation studyZiad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.American Heart Journal|May 17, 2018
Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT)Kanjana S Perera, Mukul Sharma, Stuart J Connolly, et al.Nature|May 18, 2017
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunitySydney R Gordon, Roy L Maute, Ben W Dulken, et al.Pageof 137